ylliX - Online Advertising Network
Company Ticker News

Merck, Johnson & Johnson and Bristol-Myers Seen as Most Active in M&A

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

Fierce Pharma reported RBC Capital Markets said a nearly 10% drop in biotech stocks for the first six months of the year could ignite a bonanza of second-half deals.

...read full article on GuruFocus

ylliX - Online Advertising Network